ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 130 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $293,604 | -91.3% | 451,698 | -77.0% | 0.00% | -85.7% |
| Q3 2022 | $3,373,000 | +334.1% | 1,961,127 | +213.0% | 0.01% | +250.0% |
| Q2 2022 | $777,000 | +447.2% | 626,531 | +379.4% | 0.00% | – |
| Q4 2021 | $142,000 | -85.0% | 130,700 | -74.8% | 0.00% | -100.0% |
| Q3 2021 | $944,000 | +667.5% | 518,868 | +964.1% | 0.00% | +300.0% |
| Q4 2020 | $123,000 | -7.5% | 48,763 | -7.8% | 0.00% | 0.0% |
| Q3 2020 | $133,000 | -61.1% | 52,881 | -49.3% | 0.00% | -50.0% |
| Q2 2020 | $342,000 | -39.6% | 104,335 | -29.1% | 0.00% | -33.3% |
| Q1 2019 | $566,000 | -21.3% | 147,240 | -61.7% | 0.00% | -57.1% |
| Q4 2018 | $719,000 | +212.6% | 384,016 | +435.0% | 0.01% | +600.0% |
| Q3 2018 | $230,000 | – | 71,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |